Urology Flashcards
Benign Prostatic Hyperplasia
Pathology (2)
Benign nodular or diffuse proliferation of musculofibrous and glandular layers of the prostate
Inner (transitional) zone enlarges in contrast to peripheral layer expansion seen in prostate cancer
Benign Prostatic Hyperplasia
Signs + symptoms (10)
Nocturia Frequency Urgency Post-micturition dribbling Poor stream/flow Hesitancy Overflow incontinence Haematuria Bladder stones UTI
Benign Prostatic Hyperplasia
Investigations (5)
PR exam: smooth but enlarged prostate MSU U&E Ultrasound: large residual volume, hydronephrosis (kidney swells due to urine failing to drain from kidney to bladder) PSA: rule out cancer
Benign Prostatic Hyperplasia
Treatment (5)
Lifestyle: avoid caffeine, alcohol, bladder training
Drugs for mild disease and awaiting surgery: alpha blockers 1st (eg. tamsulosin) which reduces smooth muscle tone, then add 5alpha-reductase inhibitors (eg. finsateride)
TURP surgery
Retropubic prostatectomy
TULIP (transurethral laser-induced prostatectomy) surgery
Prostatitis
Aetiology (3)
Usually <35
Acute: S.faecalis, E.coli, chlamydia
Chronic: bacterial or non-bacterial
Prostatitis Risk factors (5)
Recent UTI Recent STI Urogenital instrumentation Intermittent catheterisation Recent prostate biopsy
Prostatitis
Signs + symptoms (5)
UTI Retention Pain Haematospermia Swollen/boggy/tender prostate on DRE
Prostatitis
Investigations (3)
Urinalysis (pyuria)
Microscopy (WCC + bacterial count)
Urine culture
Prostatitis
Treatment (2)
Levofloxacin
Analgesia
Prostate Cancer Risk factors (3)
Age (80% in men >80)
Family history increases risk by 2-3x
High testosterone
Prostate Cancer
Pathology (1)
Adenocarcinomas arising in peripheral prostate
Prostate Cancer
Signs + symptoms (8)
Asymptomatic Nocturia Hesitancy Poor stream Terminal dribbling Obstruction Weight loss/bone pain/cord compression suggest mets On DRE: hard irregular prostate
Prostate Cancer
Spread (3)
Local (seminal vesicles, bladder, rectum)
Lymphatic
Haematogenous (bone, liver, lung, adrenals)
Prostate Cancer
Investigations (6)
PSA (serum prostate enzyme produced by prostate tumour epithelial cells, poor sensitivity and specificity as raised in BPH, prostatitis, UTI, ejaculation)
Other bloods: testosterone, LFTs, FBC, U&E, creatinine
Transrectal ultrasound and biopsy
Bone scan
CT pelvis (regional staging)
MRI for staging
Prostate Cancer
PSA Normal Levels (1)
Normal serum range:0-4
Prostate Cancer
PSA Age-Related Range (4)
<50: 2.5 upper limit
50-60: 3.5 upper limit
60-70: 4.5 upper limit
>70: 6.5 upper limit
Prostate Cancer
Gleason Pathological Grading System (2)
Score 1-5 of each biopsy (well to poorly differentiated) SUM score (combined scores of 2 biggest area) is prognostic
Prostate Cancer
Treatment (5)
Multiple comorbidities/elderly: watch and wait or active surveillance Low risk (PSA <10, GS <6, T1-2a): active surveillance, radical prostatectomy, external beam radiotherapy or brachytherapy Intermediate risk (PSA 10-20, GS7 or T2b): radical prostatectomy, external beam radiotherapy +/- brachytherapy +/- hormonal therapy Locally advanced: external beam radio + hormonal or prostatectomy + radio + hormonal Metastatic: hormonal therapy +/- chemo
Prostate Cancer Hormonal therapy (2)
Surgical: bilateral orchidectomy
Chemical: LHRH analogue (inhibits testosterone fuelled tumour growth via -ve feedback), anti-androgen, oestrogen (inhibits LHRH + testosterone)
Haematuria
Non-Visible Haematuria Causes (7)
Transient: UTI, menstruation, vigorous exercise, sexual intercourse Bladder, renal, prostate cancer Stones BPH Prostatitis Urethritis Renal: IgA nephropathy
Haematuria
Visible Haematuria Causes (7)
Trauma: blunt renal injury, ureteric trauma, bladder trauma (eg. RTA, pelvic fracture)
Malignancy: bladder TCC, RCC, prostate/renal cancer
Renal: glomerulonephritis
Stones
Drugs: aminoglycosides, chemo, penicillin, NSAIDs, anticoagulants
Gynae: endometriosis
Iatrogenic: catheter, radiation cystitis, cystoscopy
Haematuria
Referral (3)
Persistent non-visible haematuria
Urgent if >45 + visible haematuria (unexplained)
Urgent if >60 + unexplained non visible haematuria + dysuria/high WCC
Bladder Cancer
Pathology (6)
Most transitional cell carcinomas
Adenocarcinomas + squamous cell cancers are rare, SCC follows schistosomiasis
Grade 1- differentiated
Grade 2- intermediate
Grade 3- poorly differentiated
80% confined to bladder mucosa, only 20% penetrate muscle
Bladder Cancer Risk factors (5)
Smoking Aromatic amines (rubber industry) Chronic cystitis Schistosomiasis (SCC) Pelvic irradiation